CIK 2013410
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 50.86% | 3 |
| Pharmaceuticals & Biotechnology | 49.14% | 7 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | NAMS | NEWAMSTERDAM PHARMA COMPANY | Unclassified | 40.77% |
| 2 | DYN | Dyne Therapeutics, Inc. | Health Care | 11.66% |
| 3 | VOR | Vor Biopharma Inc. | Health Care | 10.17% |
| 4 | ENGENE HOLDINGS INC | Unclassified | 9.08% | |
| 5 | MPLT | MapLight Therapeutics, Inc. | Health Care | 9.08% |
| 6 | DMRA | Damora Therapeutics, Inc. | Health Care | 8.75% |
| 7 | CBIO | CRESCENT BIOPHARMA, INC. | Health Care | 4.27% |
| 8 | REPL | Replimune Group, Inc. | Health Care | 2.97% |
| 9 | BCYC | BICYCLE THERAPEUTICS PLC | Health Care | 2.23% |
| 10 | ENGENE HOLDINGS INC | Unclassified | 1.01% |
7/10 names classified · sector 49.1% of weight · industry 49.1% · mkt cap 49.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 49.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/9 names) · unclassified 100.0%: NAMS, DYN, VOR, , MPLT, DMRA, CBIO, REPL, BCYC. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 9,198,900 | $294M | 40.8% | HOLD |
| 2 | DYNDYNE THERAPEUTICS INC | 4,644,386 | $84M | 11.7% | TRIM −15% |
| 3 | VORVOR BIOPHARMA INC | 4,117,354 | $73M | 10.2% | ADD 14% |
| 4 | ENGENE HOLDINGS INC | 9,632,561 | $66M | 9.1% | HOLD |
| 5 | MPLTMAPLIGHT THERAPEUTICS INC | 3,226,400 | $66M | 9.1% | HOLD |
| 6 | DMRADAMORA THERAPEUTICS INC | 2,441,000 | $63M | 8.8% | NEW |
| 7 | CBIOCRESCENT BIOPHARMA INC. | 1,677,852 | $31M | 4.3% | HOLD |
| 8 | REPLREPLIMUNE GROUP INC | 2,808,368 | $21M | 3.0% | HOLD |
| 9 | BCYCBICYCLE THERAPEUTICS PLC | 3,468,430 | $16M | 2.2% | HOLD |
| 10 | ENGENE HOLDINGS INC | 2,878,148 | $7M | 1.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| NAMSNEWAMSTERDAM PHARMA COMPANY | 10.6M | 10.9M | 10.6M | 9.2M | 9.2M | 9.2M | $294M |
| DYNDYNE THERAPEUTICS INC | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 4.6M | $84M |
| VORVOR BIOPHARMA INC | — | — | — | 380K | 3.6M | 4.1M | $73M |
| ENGENE HOLDINGS INC | 9.6M | 9.6M | 9.6M | 9.6M | 9.6M | 9.6M | $66M |
| MPLTMAPLIGHT THERAPEUTICS INC | — | — | — | — | 3.2M | 3.2M | $66M |
| DMRADAMORA THERAPEUTICS INC | — | — | — | — | — | 2.4M | $63M |
| CBIOCRESCENT BIOPHARMA INC. | — | — | — | — | 1.7M | 1.7M | $31M |
| REPLREPLIMUNE GROUP INC | 4.0M | 3.9M | 3.9M | 4.2M | 2.8M | 2.8M | $21M |
| BCYCBICYCLE THERAPEUTICS PLC | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | $16M |
| ENGENE HOLDINGS INC | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M | $7M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
